LUNG CANCER, NON-SMALL CELL
Clinical trials for LUNG CANCER, NON-SMALL CELL explained in plain language.
Never miss a new study
Get alerted when new LUNG CANCER, NON-SMALL CELL trials appear
Sign up with your email to follow new studies for LUNG CANCER, NON-SMALL CELL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to outsmart drug-resistant lung cancer
Disease control Not yet recruitingThis study tests whether adding capivasertib to osimertinib can help people with a specific type of advanced lung cancer whose disease has worsened after initial treatment. About 53 adults with EGFR-mutant NSCLC and additional PIK3CA/AKT1/PTEN gene changes will receive the two dr…
Matched conditions: LUNG CANCER, NON-SMALL CELL
Phase: PHASE1, PHASE2 • Sponsor: Shanxi Province Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New drug combo aims to shrink tough lung cancers
Disease control Not yet recruitingThis Phase 2 trial tests a drug called ivonescimab, either alone or with chemotherapy, in people with advanced non-small cell lung cancer that has certain genetic changes. The study aims to see if the treatment can shrink tumors and control the cancer. About 46 participants will …
Matched conditions: LUNG CANCER, NON-SMALL CELL
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New cell therapy trial hopes to tackle tough cancers
Disease control Not yet recruitingThis early-phase trial tests SL-28, a cell therapy made from donor immune cells, in 60 people with advanced solid tumors (like lung, pancreatic, or breast cancer) that haven't responded to standard treatments. The study aims to find a safe dose and see if the therapy can shrink t…
Matched conditions: LUNG CANCER, NON-SMALL CELL
Phase: PHASE1, PHASE2 • Sponsor: Second Life Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Exercise before and during chemotherapy may boost treatment success
Symptom relief Not yet recruitingThis study tests whether a supervised exercise program, started two weeks before chemotherapy and continued for 16 weeks during treatment, can help adults aged 35 to 65 with breast, lung, or colon cancer tolerate chemotherapy better. The goal is to see if participants can receive…
Matched conditions: LUNG CANCER, NON-SMALL CELL
Phase: NA • Sponsor: University of Vic - Central University of Catalonia • Aim: Symptom relief
Last updated Jun 27, 2026 12:02 UTC
-
Spit and blood may predict who benefits from lung cancer immunotherapy
Knowledge-focused Not yet recruitingThis study looks at sputum and blood samples from 50 adults with advanced non-small cell lung cancer who are starting immunotherapy. Researchers want to find immune cell changes that could predict which patients will respond well to treatment. The goal is to better understand the…
Matched conditions: LUNG CANCER, NON-SMALL CELL
Phase: NA • Sponsor: University Hospital, Tours • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
Lung surgery ventilation showdown: which setting saves lungs?
Knowledge-focused Not yet recruitingThis study looks at the best way to use a breathing machine during lung surgery to prevent lung problems after the operation. It will involve 650 adults over 50 having lung surgery. The goal is to find which breathing settings cause the fewest lung complications like pneumonia or…
Matched conditions: LUNG CANCER, NON-SMALL CELL
Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
Can a simple blood test predict cancer treatment success?
Knowledge-focused Not yet recruitingThis study will collect blood samples from 620 adults with cancer (including lung cancer) to look for tiny markers released by tumors. Researchers want to see if these markers can help predict how well treatments work or when the cancer might come back. The study does not test a …
Matched conditions: LUNG CANCER, NON-SMALL CELL
Phase: NA • Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle • Aim: Knowledge-focused
Last updated Jun 26, 2026 18:59 UTC